Hepatoblastoma risk factors: Difference between revisions
Jump to navigation
Jump to search
Nawal Muazam (talk | contribs) No edit summary |
Nawal Muazam (talk | contribs) No edit summary |
||
Line 17: | Line 17: | ||
| style="padding: 5px 5px; background: #DCDCDC; font-weight: bold" align=center | '''[[Aicardi syndrome]]'''|| style="padding: 5px 5px; background: #F5F5F5;" | | | style="padding: 5px 5px; background: #DCDCDC; font-weight: bold" align=center | '''[[Aicardi syndrome]]'''|| style="padding: 5px 5px; background: #F5F5F5;" | | ||
:* Agenesis of the corpus callosum, chorioretinal lacunae, and infantile spasms, with a characteristic facies. | :* Agenesis of the corpus callosum, chorioretinal lacunae, and [[infantile spasms]], with a characteristic facies. | ||
|- | |- | ||
| style="padding: 5px 5px; background: #DCDCDC; font-weight: bold" align=center | '''[[Beckwith-Wiedemann syndrome]]'''|| style="padding: 5px 5px; background: #F5F5F5;"| | | style="padding: 5px 5px; background: #DCDCDC; font-weight: bold" align=center | '''[[Beckwith-Wiedemann syndrome]]'''|| style="padding: 5px 5px; background: #F5F5F5;"| | ||
:* Hemihypertrophy, hemihyperplasia. | :* [[Hemihypertrophy]], hemihyperplasia. | ||
|- | |- | ||
Line 41: | Line 41: | ||
| style="padding: 5px 5px; background: #DCDCDC; font-weight: bold" align=center | '''[[Simpson-Golabi-Behmel syndrome]]'''|| style="padding: 5px 5px; background: #F5F5F5;"| | | style="padding: 5px 5px; background: #DCDCDC; font-weight: bold" align=center | '''[[Simpson-Golabi-Behmel syndrome]]'''|| style="padding: 5px 5px; background: #F5F5F5;"| | ||
:*Macroglossia, macrosomia, renal and skeletal abnormalities, and increased risk of [[Wilms tumor]]. | :*[[Macroglossia]], [[macrosomia]], renal and skeletal abnormalities, and increased risk of [[Wilms tumor]]. | ||
|- | |- | ||
|style="padding: 5px 5px; background: #DCDCDC; font-weight: bold" align=center | '''[[Trisomy 18]], other trisomies'''|| style="padding: 5px 5px; background: #F5F5F5;" | | |style="padding: 5px 5px; background: #DCDCDC; font-weight: bold" align=center | '''[[Trisomy 18]], other trisomies'''|| style="padding: 5px 5px; background: #F5F5F5;" | | ||
:*[[Trisomy 18]]: [[Microcephaly]] and [[micrognathia]], clenched fists with overlapping fingers, and failure to thrive. Most patients (>90%) die in the first month of life. | :*[[Trisomy 18]]: [[Microcephaly]] and [[micrognathia]], clenched fists with overlapping fingers, and [[failure to thrive]]. Most patients (>90%) die in the first month of life. | ||
|} | |} |
Revision as of 22:53, 13 November 2015
Hepatoblastoma Microchapters |
Diagnosis |
---|
Treatment |
Case Studies |
Hepatoblastoma risk factors On the Web |
American Roentgen Ray Society Images of Hepatoblastoma risk factors |
Risk calculators and risk factors for Hepatoblastoma risk factors |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1];Associate Editor(s)-in-Chief: Nawal Muazam M.D.[2]
Overview
Common risk factors in the development of hepatoblastoma are Aicardi syndrome, Beckwith-Wiedemann syndrome, familial adenomatous polyposis, low birth weight infants, and glycogen storage diseases.[1]
Risk Factors
The table below lists risk factors for hepatoblastoma:[1]
Associated Disorder | Clinical findings |
---|---|
Aicardi syndrome |
|
Beckwith-Wiedemann syndrome |
|
Familial adenomatous polyposis |
|
Glycogen storage diseases I–IV |
|
Low birth weight infants |
|
Simpson-Golabi-Behmel syndrome |
|
Trisomy 18, other trisomies |
|
References
- ↑ 1.0 1.1 Risk factors. National Cancer Institute 2015. http://www.cancer.gov/types/liver/hp/child-liver-treatment-pdq#link/_570_toc. Accessed on October 28, 2015